Article info
Editorial
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do
- Dr Richard Steeds, Department of Cardiology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK; Richard.Steeds{at}uhb.nhs.uk
Citation
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do
Publication history
- First published January 27, 2009.
Online issue publication
March 15, 2016
Article Versions
- Previous version (15 March 2016).
- Previous version (15 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and British Cardiovascular Society